Iceland· IS-EU/1/19/1381/001
LysaKare
A arginin und lysin product containing argininum inn hýdróklóríð,lysine hydrochloride, registered in Iceland by Novartis Europharm Limited*. The same ATC class is registered in 8 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Arginin und lysin is registered in 8 of 19 countries.
Countries holding a registration under ATC V03AF11 (arginin und lysin), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 5 of them publish a price we can compare per daily dose
Arginin und lysin · ATC V03AF11
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Argininum INN hýdróklóríð,Lysine hydrochloride
- Manufacturer
- Novartis Europharm Limited*
- Country
- Iceland (IS)
- ATC code
- V03AF11
- ATC class
- Arginin und Lysin
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Arginin und lysin in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomArginine 25g/1litre / Lysine 25g/1litre infusion bagsSpecial Order
- SpainLYSAKARE 25 G/25 G SOLUCION PARA PERFUSIONNovartis Europharm Limited
- FinlandLysakareNovartis Europharm Limited
- FranceLYSAKARE 25 g/25 g, solution pour perfusionNOVARTIS EUROPHARM (IRLANDE)
- IrelandLysaKare 25 g/25 g Solution for infusionNovartis Europharm Limited
- PolandLysaKareAdvanced Accelerator Applications
- CzechiaLYSAKARENovartis Europharm Limited, Dublin
- SwedenLysaKare 25 mg / 25 mg Infusionsvätska, lösningNovartis Europharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Liechtenstein · Lysakare
- Norway · Lysakare
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/015dcdfa-d197-40d8-8e0b-1dbc1ac363a8 GET /v1/drugs/015dcdfa-d197-40d8-8e0b-1dbc1ac363a8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Innrennslislyf, lausn",
"source": "lyfjastofnun",
"atc_raw": "V03AF11",
"marketed": false,
"strength": "25 g/25 g",
"ma_number": "EU/1/19/1381/001",
"substance": "Argininum INN hýdróklóríð,Lysine hydrochloride",
"other_info": null,
"legal_status": "(R) Lyfseðilsskylt\r\n(H) Sjúkrahúsmerkt",
"ma_issued_serial": "43671"
}See everything about arginin und lysin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.